Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation
Professor Julia Vorholt's work has changed how we think about plant health. Her innovative research on plant microbiomes ...
Access to Compounded GLP-1s Is Drying Up. Here’s What to Know About the Copycat Weight-Loss Drugs.
This story mentions weight, weight loss, and/or GLP-1 drugs. In the last few years, GLP-1s, prescription weight-loss ...
Zacks Investment Research on MSN21h
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
Shares of Viking Therapeutics VKTX gained more than 11% on Wednesday after the company announced that it had signed a broad ...
Le Lézard1d
Vivani Medical Achieves First Implant and Full Enrollment in the First-in-Human Clinical Trial of GLP-1 Implant NPM-115 in Obese or Overweight Adults
Vivani Medical, Inc. ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced the successful administration of its ...
Medical Device Network on MSN1d
Vivani Medical to spin-off neurostim business Cortigent as public company
Vivani was created in 2022 when subdermal drug implant company Nano Precision Medical merged with implantable visual ...
pharmaphorum3d
Tirzepatide gets a big win in obesity-related heart failure
Eli Lilly's tirzepatide has been shown to significantly cut cardiovascular risks in patients with obesity and a form of ... HFpEF trial. Novo Nordisk recently pulled its FDA application for ...
pharmaphorum6d
Lilly doubles down on Dexcom tech for connected insulin devices
The pump-based platform will be a hybrid closed-loop device that will combine an insulin pump, CGM and a dedicated handheld controller or smartphone application ... like Novo Nordisk and Sanofi ...
Verywell Health on MSN2d
Novo Nordisk Offers Wegovy for $499 a Month in Direct-to-Consumer Program
Novo Nordisk announced a direct-to-consumer program that allows patients to buy Wegovy out of pocket at a lower cost.
NVO LAWSUIT ALERT: Levi & Korsinsky Notifies Novo Nordisk A/S Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / March 13, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a ...
Levi & Korsinsky Notifies Shareholders of Novo Nordisk A/S(NVO) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESS Newswire / March 11, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a ...
Pulmonology Advisor1d
Novo Nordisk Provides Direct-to-Patient Delivery Option for Wegovy
Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.
The Australian Financial Review4d
Ozempic maker says its Australian market could be half the population
Gift 5 articles to anyone you choose each month when you subscribe. Danish pharmaceutical giant Novo Nordisk says about 13 million Australians are living with obesity or are overweight ...